Accelr8 Technology Corp. has released two commercial versions of its biotin coated OptArray microarray protein chip slides. The slides are the first products to use the company's proprietary OptiChem coatings.

Genzyme Molecular Oncology, a division of Genzyme Corporation has signed an exclusive patent license for use of a gene believed to be implicated in metastatic colon cancer. Discovered at The Johns Hopkins University, the phosphatase enzyme called PRL-3 has been shown to be expressed in much higher levels in colon cancer cells that have metastasized to the liver than in non-metastatic colon tumors and normal colon tissue.

Molecular Devices Corp. has launched two new assay kits using its proprietary IMAP technology. The kits -- the p38 Assay Kit and MAPKAP K2 Assay Kit -- incorporate kinase enzymes from Upstate Biotechnology. Both the p38 and MAPKAP K2 are important targets in the development of new therapies for cancer and arthritis.

PerkinElmer Life Sciences has introduced a full set of gene probes for use in genetic typing of type 1 diabetes based on PerkinElmer Life Sciences' DELFIA technology.

Molecular Biology - March 2002
Molecular Biology - February 2002
Molecular Biology - January 2002
Molecular Biology - December 2001
Molecular Biology - November 2001
Molecular Biology - October 2001
Molecular Biology - September 2001
Molecular Biology - Summer 2001
Molecular Biology - May 2001
Molecular Biology - April 2001
Molecular Biology - March 2001
Molecular Biology - February 2001
Molecular Biology - January 2001
Molecular Biology - December 2000
Molecular Biology - November 2000
Molecular Biology - October 2000
Molecular Biology - September 2000
Molecular Biology - July - August 2000
Molecular Biology - June 2000
Molecular Biology - May 2000
Molecular Biology - April 2000
Molecular Biology - March 2000
Molecular Biology - Febuary 2000
Molecular Biology - January 2000
Molecular Biology - December 1999
Molecular Biology - November 1999
Molecular Biology - October 1999
Molecular Biology - September 1999